TERT is the rate-limiting component of the telomerase complex [4], and its expression, usually absent in normal somatic cells, is detectable in ~90% of human malignancies [5], allowing cancer cells to overcome the replicative crisis caused by telomere attrition [6,7]. This evidence concerns the gene TERT and cancer.